Bavarian Nordic
Hellerup, DenmarkFounded 1994Industry
Bavarian Nordic is a Danish vaccine company that supplies JYNNEOS, a non-replicating smallpox and mpox vaccine, to governments for preparedness. Its US government work includes a long-running BARDA contract for freeze-dried JYNNEOS, and it also has European Commission and other national supply agreements.
What it does
Threats covered
Profile
Bavarian Nordic is a vaccine company listed on Nasdaq Copenhagen (BAVA) and headquartered in Hellerup, Denmark. Its company materials give 1994 as its founding year, not 1992 as some listings do.
More profile
Its JYNNEOS vaccine is a non-replicating smallpox and mpox vaccine. In May 2025 the US government exercised 143.6 million dollars in options under the existing 2017 ten-year contract with the Biomedical Advanced Research and Development Authority for freeze-dried JYNNEOS, with most deliveries planned for 2026.
In May 2026 it received a further 97 million dollar option to complete the original order of 11.5 million doses, with manufacturing and delivery planned for 2027. Biodefence is one segment of a wider vaccine business.
The 2025 annual report is published on its website.
Ownership
Publicly listed on Nasdaq Copenhagen (BAVA)
Parent: none (publicly listed) (checked)
Sources (4)
Not verified or not found
- Exact date of incorporation: only the year 1994 was read.
- Revenue share from biodefence: not read.
Questions
What does Bavarian Nordic do?
Bavarian Nordic is a Danish vaccine company that supplies JYNNEOS, a non-replicating smallpox and mpox vaccine, to governments for preparedness. Its US government work includes a long-running BARDA contract for freeze-dried JYNNEOS, and it also has European Commission and other national supply agreements.
Where is Bavarian Nordic based?
HQ (as found): Hellerup. HQ country: DK.
Who owns Bavarian Nordic?
Publicly listed on Nasdaq Copenhagen (BAVA). Parent: none (publicly listed) (checked)
Profiles are compiled from public sources and sampled-checked, not fully audited. Last verified 17 October 2026. Report a correction